|
US4296206A
(en)
|
1980-04-30 |
1981-10-20 |
United States Of America |
Irreversible anti-glucocorticoids
|
|
FR2528434B1
(fr)
|
1982-06-11 |
1985-07-19 |
Roussel Uclaf |
Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
|
|
ZA8231B
(en)
|
1981-01-09 |
1982-11-24 |
Roussel Uclaf |
New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
|
|
US4978657A
(en)
|
1981-01-09 |
1990-12-18 |
Roussel Uclaf |
Novel 11β-substituted-19-nor-steroids
|
|
FR2522328B1
(fr)
|
1982-03-01 |
1986-02-14 |
Roussel Uclaf |
Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
|
|
FR2639045B2
(fr)
|
1982-03-01 |
1994-07-29 |
Roussel Uclaf |
Nouveaux produits derives de la structure 3-ceto-delta-4,9-19-nor steroides et leur application comme medicaments
|
|
DE3438994A1
(de)
|
1984-10-22 |
1986-04-24 |
Schering AG, Berlin und Bergkamen, 1000 Berlin |
Antigestagene, glukokortikoide und prostaglandine zur geburtseinleitung oder fuer den schwangerschaftsabbruch
|
|
FR2576025B1
(fr)
|
1985-01-14 |
1987-01-23 |
Roussel Uclaf |
Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
|
|
AU580843B2
(en)
|
1985-02-07 |
1989-02-02 |
Schering Aktiengesellschaft |
11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
|
|
DE3506785A1
(de)
|
1985-02-22 |
1986-08-28 |
Schering AG, Berlin und Bergkamen, 1000 Berlin |
11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
US5380840A
(en)
|
1985-09-12 |
1995-01-10 |
The Upjohn Company |
Triazinylpiperazinyl steroids
|
|
FR2598421B1
(fr)
|
1986-05-06 |
1988-08-19 |
Roussel Uclaf |
Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
|
|
DE3761308D1
(de)
|
1986-07-23 |
1990-02-08 |
Akzo Nv |
18-phenylestrane-derivate.
|
|
DE3625315A1
(de)
|
1986-07-25 |
1988-01-28 |
Schering Ag |
11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
US4774236A
(en)
|
1986-09-17 |
1988-09-27 |
Research Triangle Institute |
17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them
|
|
US4861763A
(en)
|
1986-09-17 |
1989-08-29 |
Research Triangle Institute |
17 α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and their progestational use
|
|
US4921638A
(en)
|
1986-11-05 |
1990-05-01 |
The Upjohn Company |
17β-cyano-9α,17α-dihydroxyandrost-4-en-3-one
|
|
DE3708942A1
(de)
|
1987-03-18 |
1988-09-29 |
Schering Ag |
19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
DE3723788A1
(de)
|
1987-07-16 |
1989-01-26 |
Schering Ag |
11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
FR2618783B1
(fr)
|
1987-07-30 |
1991-02-01 |
Roussel Uclaf |
Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
|
|
JP2785023B2
(ja)
|
1987-12-30 |
1998-08-13 |
ルセル―ユクラフ |
１７α位置を置換された１７β―ＯＨ―１９―ノルステロイドの新誘導体、その製造方法、その薬剤としての使用及びそれを含有する製薬組成物
|
|
DE3820948A1
(de)
|
1988-06-16 |
1989-12-21 |
Schering Ag |
10ss, 11ss-ueberbrueckte steroide
|
|
US4954490A
(en)
|
1988-06-23 |
1990-09-04 |
Research Triangle Institute |
11 β-substituted progesterone analogs
|
|
US5348729A
(en)
|
1988-11-30 |
1994-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Evaluative means for detecting inflammatory reactivity
|
|
DD289541A5
(de)
|
1989-08-04 |
1991-05-02 |
��@�K@�������������@�K@��������������@��������k�� |
Verfahren zur herstellung von 11beta-aryl-16 alpha, 17 alph-cyclohexanoestra-4,9-dienen
|
|
US5276023A
(en)
|
1989-08-08 |
1994-01-04 |
Roussel Uclaf |
19-nor-steroid esters
|
|
FR2651233B1
(fr)
|
1989-08-23 |
1991-12-13 |
Roussel Uclaf |
Nouveaux acides omega-phenylamino alcanouiques substitues sur le noyau aromatique par un radical derive de 19-norsterouides, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.
|
|
US5173405A
(en)
|
1990-01-23 |
1992-12-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of arsenite to reversibly block steroid binding to glucocorticoid receptors in the presence of other steroid receptors
|
|
US5616458A
(en)
|
1990-03-14 |
1997-04-01 |
Board Of Regents, University Of Tx System |
Tripterygium wilfordii hook F extracts and components, and uses thereof
|
|
DE4042004A1
(de)
|
1990-12-22 |
1992-06-25 |
Schering Ag |
14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene
|
|
US5439913A
(en)
|
1992-05-12 |
1995-08-08 |
Schering Aktiengesellschaft |
Contraception method using competitive progesterone antagonists and novel compounds useful therein
|
|
EP0683172B1
(en)
|
1994-05-19 |
1997-08-13 |
Akzo Nobel N.V. |
11,21-Bisphenyl-19-norpregnane derivatives
|
|
US6051573A
(en)
|
1994-06-28 |
2000-04-18 |
Alcon Laboratories, Inc. |
Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists
|
|
EP1043325B1
(en)
|
1994-12-22 |
2004-06-16 |
Ligand Pharmaceuticals Incorporated |
Steroid receptor modulator compounds and methods
|
|
US5696127A
(en)
|
1994-12-22 |
1997-12-09 |
Ligand Pharmaceuticals Incorporated |
Steroid receptor modulator compounds and methods
|
|
IL118974A
(en)
|
1995-08-17 |
2001-09-13 |
Akzo Nobel Nv |
History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
|
|
AU5729098A
(en)
|
1996-12-24 |
1998-07-17 |
Zymogenetics Inc. |
Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes
|
|
EP0903146A1
(en)
|
1997-09-23 |
1999-03-24 |
Applied Research Systems ARS Holdings N.V. |
21-Hydroy-6,19-oxidoprogesterone (210h-60p) as antiglucocorticoid
|
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
IL180679A0
(en)
|
2000-10-27 |
2009-02-11 |
Pfizer Prod Inc |
Process for the preparation of non-steroidal glucocorticoid receptor modulators
|
|
AU2002366217A1
(en)
|
2001-11-23 |
2003-06-10 |
Akzo Nobel N.V. |
Treatment of major depressive disorder using glucocorticoid receptor antagonists
|
|
US8543214B2
(en)
|
2002-10-15 |
2013-09-24 |
Medtronic, Inc. |
Configuring and testing treatment therapy parameters for a medical device system
|
|
CA2504751C
(en)
|
2002-11-05 |
2013-02-05 |
Corcept Therapeutics, Inc. |
Methods for treating gastroesophageal reflux disease
|
|
PT1761497E
(pt)
|
2004-01-09 |
2008-09-25 |
Corcept Therapeutics Inc |
Azadecalinas moduladoras do receptor de glucocorticóides
|
|
CA2558899C
(en)
|
2004-03-09 |
2013-02-05 |
Corcept Therapeutics, Inc. |
Fused ring azadecalin glucocorticoid receptor modulators
|
|
US7576076B2
(en)
|
2004-07-02 |
2009-08-18 |
Corcept Therapeutics, Inc. |
Modified pyrimidine glucocorticoid receptor modulators
|
|
WO2007131041A2
(en)
|
2006-05-02 |
2007-11-15 |
Corcept Therapeutics, Inc. |
The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2
|
|
EA200970401A1
(ru)
|
2006-10-23 |
2009-10-30 |
Мерк Энд Ко., Инк. |
2-[1-ФЕНИЛ-5-ГИДРОКСИ ИЛИ МЕТОКСИ-4-АЛЬФА-МЕТИЛГЕКСАГИДРОЦИКЛОПЕНТА[f]ИНДАЗОЛ-5-ИЛ] ЭТИЛФЕНИЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ЛИГАНДОВ ГЛЮКОКОРТИКОИДНОГО РЕЦЕПТОРА
|
|
US8598149B2
(en)
|
2007-08-30 |
2013-12-03 |
Corcept Therapeutics, Inc. |
Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists
|
|
US20100261693A1
(en)
|
2007-10-17 |
2010-10-14 |
Ulmann Andre |
Method for treating cushing's syndrome
|
|
JP5637568B2
(ja)
|
2009-05-12 |
2014-12-10 |
コーセプト セラピューティクス， インコーポレイテッド |
固体形態および調製のためのプロセス
|
|
MY161170A
(en)
|
2011-03-18 |
2017-04-14 |
Corcept Therapeutics Inc |
Pyrimidine cyclohexyl glucocorticoid receptor modulators
|
|
US8859774B2
(en)
*
|
2012-05-25 |
2014-10-14 |
Corcept Therapeutics, Inc. |
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
|
CA2872260C
(en)
*
|
2012-05-25 |
2020-12-22 |
Corcept Therapeutics, Inc. |
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
|
ITFI20120127A1
(it)
*
|
2012-06-21 |
2013-12-22 |
Valpharma Internat Spa |
Formulazioni per la preparazione di compresse per uso orale a rilascio immediato contenenti mifepristone a basso dosaggio, compresse così ottenute e loro processo di preparazione.
|
|
US20140170768A1
(en)
|
2012-12-14 |
2014-06-19 |
Joel R. L. Ehrenkranz |
Method for monitoring and assessing pituitary function
|
|
US9943526B2
(en)
|
2015-04-21 |
2018-04-17 |
Corcept Therapeutics, Inc. |
Optimizing mifepristone levels for cushing's patients
|
|
KR20180052120A
(ko)
|
2015-08-13 |
2018-05-17 |
코어셉트 쎄라퓨틱스, 잉크. |
Acth-의존성 쿠싱 증후군을 감별 진단하는 방법
|